江苏省疾病预防控制中心（江苏省预防医学科学院）

首页 > 疾控服务 > 科研工作

2023-06-12

发稿:

审稿:

来源:

Study protocol for Safety,immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults:a multicentre,open-label phase 3 trial

字体 :大中小

打印

　　A CLINICAL TRIAL OF HETEROLOGOUS BOOSTER IMMUNIZATION WITH RECOMBINANT COVID-19 VACCINE (ADENOVIRUS TYPE 5 VECTOR) FOR INHALATION AFTER PRIMARY SERIES OF INACTIVATED COVID-19 VACCINE

　　Project No.: Protocol No.: JSVCT137

　　download:Protocol - V1.2_EN_Clean-20230331.pdf